zardaverine has been researched along with Respiratory Distress Syndrome in 1 studies
zardaverine: structure given in first source
zardaverine : A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schermuly, RT | 1 |
| Leuchte, H | 1 |
| Ghofrani, HA | 1 |
| Weissmann, N | 1 |
| Rose, F | 1 |
| Kohstall, M | 1 |
| Olschewski, H | 1 |
| Schudt, C | 1 |
| Grimminger, F | 1 |
| Seeger, W | 1 |
| Walmrath, D | 1 |
1 other study available for zardaverine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Zardaverine and aerosolised iloprost in a model of acute respiratory failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Anim | 2003 |